Trade Summary

4 days ago, Weaver Gregory L, serving as CFO at Altimmune, Inc. (ALT), purchased 10,000 shares at $3.15 per share, for a total transaction value of $31,499.00. Following this transaction, Weaver Gregory L now holds 38,078 shares of ALT.

This purchase represents a 36.00% increase in Weaver Gregory L's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 1, 2026, meaning the disclosure happened on the same day as the trade.

Altimmune, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.